-
Chardan Capital Reiterates Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR)
ソース: Buzz FX / 11 2 2025 08:37:10 America/New_York
Chardan Capital Reiterates Buy Rating for Arrowhead Pharmaceuticals (NASDAQ:ARWR) Written by MarketBeat February 11, 2025 Share Link copied to clipboard. Arrowhead Pharmaceuticals ( NASDAQ:ARWR - Get Free Report ) 's stock had its "buy" rat
Read more...